HIF-dependent antitumorigenic effect of antioxidants in vivo.

The antitumorigenic activity of antioxidants has been presumed to arise from their ability to squelch DNA damage and genomic instability mediated by reactive oxygen species (ROS). Here, we report that antioxidants inhibited three tumorigenic models in vivo. Inhibition of a MYC-dependent human B lymphoma model was unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF)-1 levels in a prolyl hydroxylase 2 and von Hippel-Lindau protein-dependent manner. Ectopic expression of an oxygen-independent, stabilized HIF-1 mutant rescued lymphoma xenografts from inhibition by two antioxidants: N-acetylcysteine and vitamin C. These findings challenge the paradigm that antioxidants diminish tumorigenesis primarily through decreasing DNA damage and mutations and provide significant support for a key antitumorigenic effect of diminishing HIF levels.

[1]  W. Kaelin,et al.  Proline hydroxylation and gene expression. , 2005, Annual review of biochemistry.

[2]  R. Cole,et al.  RACK1 Competes with HSP90 for Binding to HIF-1α and is Required for O2-independent and HSP90 Inhibitor-induced Degradation of HIF-1α , 2007 .

[3]  L. Pauling,et al.  Ascorbic acid and cancer: a review. , 1979, Cancer research.

[4]  B. Blaisdell,et al.  Effect of dietary ascorbic acid on the incidence of spontaneous mammary tumors in RIII mice. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Kiichi Hirota,et al.  Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 , 2003, Circulation research.

[6]  Brian Keith,et al.  Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation , 2003, Molecular and Cellular Biology.

[7]  G. Evan,et al.  The pathological response to DNA damage does not contribute to p53-mediated tumour suppression , 2006, Nature.

[8]  G. Semenza,et al.  Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. , 2006, Cancer research.

[9]  M. Aitio.  N-acetylcysteine -- passe-partout or much ado about nothing? , 2006, British journal of clinical pharmacology.

[10]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[11]  G. Semenza,et al.  HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. , 2007, Cancer cell.

[12]  W. Kaelin,et al.  ROS: really involved in oxygen sensing. , 2005, Cell metabolism.

[13]  Ricky A. Sharma,et al.  Biological Relevance of Adduct Detection to the Chemoprevention of Cancer , 2004, Clinical Cancer Research.

[14]  W. Morgan,et al.  Persistent oxidative stress in chromosomally unstable cells. , 2003, Cancer research.

[15]  M. Poirier.  Chemical-induced DNA damage and human cancer risk , 2004, Nature Reviews Cancer.

[16]  L. Huang,et al.  HIF‐1α induces cell cycle arrest by functionally counteracting Myc , 2004 .

[17]  Thierry Fest,et al.  c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[19]  A. Harris,et al.  HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression , 2005 .

[20]  G. Wahl,et al.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.

[21]  John D Gordan,et al.  HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. , 2007, Cancer cell.

[22]  A. Giaccia,et al.  HIF-1 as a target for drug development , 2003, Nature Reviews Drug Discovery.

[23]  B. Narayanan,et al.  Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. , 2006, Current cancer drug targets.

[24]  J. Pollack,et al.  Comparative genomic hybridization on mouse cDNA microarrays and its application to a murine lymphoma model , 2005, Oncogene.

[25]  G. Mantovani,et al.  Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress , 2003, Journal of Molecular Medicine.

[26]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[27]  R. Schiestl,et al.  Effect of N-Acetyl Cysteine on Oxidative DNA Damage and the Frequency of DNA Deletions in Atm-Deficient Mice , 2004, Cancer Research.

[28]  J. Pouysségur,et al.  HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.

[29]  R. Schiestl,et al.  Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. , 2006, DNA repair.

[30]  U. Weidle,et al.  Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.

[31]  Massimo Zeviani,et al.  Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. , 2005, Cell metabolism.

[32]  P. Schumacker,et al.  Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. , 2005, Cell metabolism.

[33]  D. Felsher,et al.  Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. , 2003, Blood.

[34]  P. Chumakov,et al.  The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.

[35]  C. Dalgard,et al.  Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1* , 2005, Journal of Biological Chemistry.

[36]  A. Harris,et al.  Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. , 2003, Cancer research.

[37]  Arvind P Pathak,et al.  Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. , 2006, Cancer research.

[38]  M. Simon,et al.  HIFs, hypoxia, and vascular development. , 2004, Current topics in developmental biology.

[39]  Robert D Cardiff,et al.  Developmental Context Determines Latency of MYC-Induced Tumorigenesis , 2004, PLoS biology.

[40]  J. Pouysségur,et al.  Hypoxia signalling controls metabolic demand. , 2007, Current opinion in cell biology.